r.rotation.to⌕ Search stocks, people, sectors
Following this device: dark.
Request a free account

Follow the people · Insider

KM

Kimberly Manhard

Insider · Director · INBX

Kimberly Manhard files insider transactions with the SEC as a director of Inhibrx. We hold 2 disclosed purchases and sales filed since 22 December 2006, 2 of them in the last 90 days.

  • Files for 6 companiesINBX, INXB, HRTX, RDEA and 2 more
  • Disclosed buys and sells2 in all, 2 in the last 90 days
  • Last disclosure10 September 2026

Positions held

6 posts we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 21 August 2020 — 9 September 2026Director · Inhibrx 14 Form 4 lines · source: SEC Form 4
  • Filed 30 May 2024 — 30 May 2024Director · Inhibrx Biosciences 1 Form 4 line · source: SEC Form 4
  • Filed 12 December 2014 — 13 April 2023EVP, Drug Development · Heron Therapeutics, Inc. /de/ 96 Form 4 lines · source: SEC Form 4
  • Filed 2 January 2008 — 19 June 2012SVP, Regulatory & Dev Ops · Ardea Biosciences, Inc./DE 132 Form 4 lines · source: SEC Form 4
  • Filed 26 July 2007 — 26 July 2007Sr. VP, Reg Affairs & Ops · Ardea Biosciences, Inc./DE 1 Form 4 line · source: SEC Form 4
  • Filed 21 December 2006 — 21 December 2006Sr VP Reg Affairs & Operations · Intrabiotics Pharmaceuticals Inc /de 1 Form 4 line · source: SEC Form 4

Every transaction

245 transactions from SEC Form 4 — one row each, sort any column, open a row for the filing
245 of 245 shown
9 Sep 202610 Sep 2026SEC Form 41 dsold on the open marketInhibrx Biosciences500 sharesdown −3.2%down −1.9%
8 Sep 202610 Sep 2026SEC Form 42 dsold on the open marketInhibrx Biosciences500 sharesdown −4.4%down −1.9%
3 Jun 20264 Jun 2026SEC Form 41 dwas grantednot a tradeInhibrx Biosciencesderivative15,000 sharesup +14.8%up +19.7%
28 May 202529 May 2025SEC Form 41 dwas grantednot a tradeInhibrx Biosciencesderivative15,000 sharesup +746.4%up +694.7%
28 Aug 202430 Aug 2024SEC Form 42 dbought on the open marketInhibrx Biosciences10,000 sharesup +682.7%up +650.5%
30 May 202430 May 2024SEC Form 40 dwas grantednot a tradeInhibrx Biosciencesderivative30,000 sharesup +589.0%up +589.0%
30 May 202430 May 2024SEC Form 40 dreturned to the issuernot a tradeInhibrxderivative3,500 sharesup +589.0%up +589.0%
30 May 202430 May 2024SEC Form 40 dreturned to the issuernot a tradeInhibrxderivative15,000 sharesup +589.0%up +589.0%
30 May 202430 May 2024SEC Form 40 dreturned to the issuernot a tradeInhibrxderivative15,000 sharesup +589.0%up +589.0%
30 May 202430 May 2024SEC Form 40 dreturned to the issuernot a tradeInhibrxderivative15,000 sharesup +589.0%up +589.0%
30 May 202430 May 2024SEC Form 40 dreturned to the issuernot a tradeInhibrxderivative17,259 sharesup +589.0%up +589.0%
25 May 202330 May 2023SEC Form 45 dwas grantednot a tradeInhibrxderivative15,000 shares——
13 Apr 202317 Apr 2023SEC Form 44 dexercised options overnot a tradeHeron Therapeutics, Inc. /de/derivative1,250 sharesdown −89.0%down −89.0%
13 Apr 202317 Apr 2023SEC Form 44 dexercised options overnot a tradeHeron Therapeutics, Inc. /de/derivative4,564 sharesdown −89.0%down −89.0%
13 Apr 202317 Apr 2023SEC Form 44 dexercised options overnot a tradeHeron Therapeutics, Inc. /de/1,250 sharesdown −89.0%down −89.0%
13 Apr 202317 Apr 2023SEC Form 44 dexercised options overnot a tradeHeron Therapeutics, Inc. /de/4,564 sharesdown −89.0%down −89.0%
13 Apr 202317 Apr 2023SEC Form 44 dhad shares withheld for taxnot a tradeHeron Therapeutics, Inc. /de/1,417 sharesdown −89.0%down −89.0%
18 Jan 202320 Jan 2023SEC Form 42 dwas grantednot a tradeHeron Therapeutics, Inc. /de/derivative149,365 sharesdown −89.9%down −89.3%
13 Jan 202317 Jan 2023SEC Form 44 dexercised options overnot a tradeHeron Therapeutics, Inc. /de/derivative1,250 sharesdown −90.0%down −90.3%
13 Jan 202317 Jan 2023SEC Form 44 dexercised options overnot a tradeHeron Therapeutics, Inc. /de/derivative4,564 sharesdown −90.0%down −90.3%
13 Jan 202317 Jan 2023SEC Form 44 dexercised options overnot a tradeHeron Therapeutics, Inc. /de/1,250 sharesdown −90.0%down −90.3%
13 Jan 202317 Jan 2023SEC Form 44 dexercised options overnot a tradeHeron Therapeutics, Inc. /de/4,564 sharesdown −90.0%down −90.3%
13 Jan 202317 Jan 2023SEC Form 44 dhad shares withheld for taxnot a tradeHeron Therapeutics, Inc. /de/2,012 sharesdown −90.0%down −90.3%
31 Oct 202217 Jan 2023SEC Form 478 dacquired or disposed of, othernot a tradeHeron Therapeutics, Inc. /de/1,655 sharesdown −91.8%down −90.3%
13 Oct 202217 Oct 2022SEC Form 44 dexercised options overnot a tradeHeron Therapeutics, Inc. /de/derivative1,250 sharesdown −91.6%down −92.0%
13 Oct 202217 Oct 2022SEC Form 44 dexercised options overnot a tradeHeron Therapeutics, Inc. /de/derivative4,564 sharesdown −91.6%down −92.0%
13 Oct 202217 Oct 2022SEC Form 44 dexercised options overnot a tradeHeron Therapeutics, Inc. /de/1,250 sharesdown −91.6%down −92.0%
13 Oct 202217 Oct 2022SEC Form 44 dexercised options overnot a tradeHeron Therapeutics, Inc. /de/4,564 sharesdown −91.6%down −92.0%
13 Oct 202217 Oct 2022SEC Form 44 dhad shares withheld for taxnot a tradeHeron Therapeutics, Inc. /de/2,012 sharesdown −91.6%down −92.0%
25 Jul 202227 Jul 2022SEC Form 42 dwas grantednot a tradeHeron Therapeutics, Inc. /de/derivative165,961 sharesdown −88.1%down −89.0%
13 Jul 202215 Jul 2022SEC Form 42 dexercised options overnot a tradeHeron Therapeutics, Inc. /de/derivative1,250 sharesdown −89.5%down −89.3%
13 Jul 202215 Jul 2022SEC Form 42 dexercised options overnot a tradeHeron Therapeutics, Inc. /de/derivative4,564 sharesdown −89.5%down −89.3%
13 Jul 202215 Jul 2022SEC Form 42 dexercised options overnot a tradeHeron Therapeutics, Inc. /de/1,250 sharesdown −89.5%down −89.3%
13 Jul 202215 Jul 2022SEC Form 42 dexercised options overnot a tradeHeron Therapeutics, Inc. /de/4,564 sharesdown −89.5%down −89.3%
13 Jul 202215 Jul 2022SEC Form 42 dhad shares withheld for taxnot a tradeHeron Therapeutics, Inc. /de/2,012 sharesdown −89.5%down −89.3%
25 May 202226 May 2022SEC Form 41 dwas grantednot a tradeInhibrxderivative15,000 shares——
3 May 20224 May 2022SEC Form 41 dsold on the open marketHeron Therapeutics, Inc. /de/1,504 sharesdown −93.4%down −93.5%
29 Apr 20224 May 2022SEC Form 45 dacquired or disposed of, othernot a tradeHeron Therapeutics, Inc. /de/1,504 sharesdown −93.0%down −93.5%
13 Apr 202215 Apr 2022SEC Form 42 dexercised options overnot a tradeHeron Therapeutics, Inc. /de/derivative1,250 sharesdown −94.8%down −94.6%
13 Apr 202215 Apr 2022SEC Form 42 dexercised options overnot a tradeHeron Therapeutics, Inc. /de/derivative4,564 sharesdown −94.8%down −94.6%
13 Apr 202215 Apr 2022SEC Form 42 dexercised options overnot a tradeHeron Therapeutics, Inc. /de/1,250 sharesdown −94.8%down −94.6%
13 Apr 202215 Apr 2022SEC Form 42 dexercised options overnot a tradeHeron Therapeutics, Inc. /de/4,564 sharesdown −94.8%down −94.6%
13 Apr 202215 Apr 2022SEC Form 42 dhad shares withheld for taxnot a tradeHeron Therapeutics, Inc. /de/2,012 sharesdown −94.8%down −94.6%
13 Jan 202214 Jan 2022SEC Form 41 dexercised options overnot a tradeHeron Therapeutics, Inc. /de/derivative1,250 sharesdown −96.2%down −96.4%
13 Jan 202214 Jan 2022SEC Form 41 dexercised options overnot a tradeHeron Therapeutics, Inc. /de/derivative4,564 sharesdown −96.2%down −96.4%
13 Jan 202214 Jan 2022SEC Form 41 dexercised options overnot a tradeHeron Therapeutics, Inc. /de/1,250 sharesdown −96.2%down −96.4%
13 Jan 202214 Jan 2022SEC Form 41 dexercised options overnot a tradeHeron Therapeutics, Inc. /de/4,564 sharesdown −96.2%down −96.4%
13 Jan 202214 Jan 2022SEC Form 41 dhad shares withheld for taxnot a tradeHeron Therapeutics, Inc. /de/2,012 sharesdown −96.2%down −96.4%
13 Oct 202115 Oct 2021SEC Form 42 dexercised options overnot a tradeHeron Therapeutics, Inc. /de/derivative1,250 sharesdown −97.0%down −97.0%
13 Oct 202115 Oct 2021SEC Form 42 dwas grantednot a tradeHeron Therapeutics, Inc. /de/derivative92,200 sharesdown −97.0%down −97.0%
13 Oct 202115 Oct 2021SEC Form 42 dwas grantednot a tradeHeron Therapeutics, Inc. /de/derivative55,320 sharesdown −97.0%down −97.0%
13 Oct 202115 Oct 2021SEC Form 42 dexercised options overnot a tradeHeron Therapeutics, Inc. /de/1,250 sharesdown −97.0%down −97.0%
13 Oct 202115 Oct 2021SEC Form 42 dhad shares withheld for taxnot a tradeHeron Therapeutics, Inc. /de/433 sharesdown −97.0%down −97.0%
13 Jul 202115 Jul 2021SEC Form 42 dexercised options overnot a tradeHeron Therapeutics, Inc. /de/1,250 sharesdown −97.7%down −97.6%
13 Jul 202115 Jul 2021SEC Form 42 dhad shares withheld for taxnot a tradeHeron Therapeutics, Inc. /de/433 sharesdown −97.7%down −97.6%
13 Jul 202115 Jul 2021SEC Form 42 dexercised options overnot a tradeHeron Therapeutics, Inc. /de/derivative1,250 sharesdown −97.7%down −97.6%
7 Jun 20218 Jun 2021SEC Form 41 dwas grantednot a tradeInhibrxderivative15,000 shares——
3 May 20214 May 2021SEC Form 41 dsold on the open marketHeron Therapeutics, Inc. /de/1,529 sharesdown −98.2%down −98.2%
30 Apr 20214 May 2021SEC Form 44 dacquired or disposed of, othernot a tradeHeron Therapeutics, Inc. /de/1,529 sharesdown −98.2%down −98.2%
13 Apr 202115 Apr 2021SEC Form 42 dexercised options overnot a tradeHeron Therapeutics, Inc. /de/1,250 sharesdown −98.1%down −98.2%
13 Apr 202115 Apr 2021SEC Form 42 dhad shares withheld for taxnot a tradeHeron Therapeutics, Inc. /de/433 sharesdown −98.1%down −98.2%
13 Apr 202115 Apr 2021SEC Form 42 dexercised options overnot a tradeHeron Therapeutics, Inc. /de/derivative1,250 sharesdown −98.1%down −98.2%
13 Jan 202115 Jan 2021SEC Form 42 dexercised options overnot a tradeHeron Therapeutics, Inc. /de/derivative1,250 sharesdown −98.3%down −98.2%
13 Jan 202115 Jan 2021SEC Form 42 dexercised options overnot a tradeHeron Therapeutics, Inc. /de/1,250 sharesdown −98.3%down −98.2%
13 Jan 202115 Jan 2021SEC Form 42 dhad shares withheld for taxnot a tradeHeron Therapeutics, Inc. /de/433 sharesdown −98.3%down −98.2%
22 Dec 202023 Dec 2020SEC Form 41 dexercised options overnot a tradeHeron Therapeutics, Inc. /de/derivative10,000 sharesdown −98.5%down −98.5%
22 Dec 202023 Dec 2020SEC Form 41 dexercised options overnot a tradeHeron Therapeutics, Inc. /de/10,000 sharesdown −98.5%down −98.5%
22 Dec 202023 Dec 2020SEC Form 41 dsold on the open marketHeron Therapeutics, Inc. /de/10,000 sharesdown −98.5%down −98.5%
13 Oct 202015 Oct 2020SEC Form 42 dwas grantednot a tradeHeron Therapeutics, Inc. /de/derivative120,000 sharesdown −98.0%down −98.0%
13 Oct 202015 Oct 2020SEC Form 42 dwas grantednot a tradeHeron Therapeutics, Inc. /de/derivative20,000 sharesdown −98.0%down −98.0%
21 Aug 202021 Aug 2020SEC Form 40 dwas grantednot a tradeInhibrxderivative17,259 shares——
1 May 20201 May 2020SEC Form 40 dsold on the open marketHeron Therapeutics, Inc. /de/1,158 sharesdown −97.7%down −97.7%
30 Apr 20201 May 2020SEC Form 41 dacquired or disposed of, othernot a tradeHeron Therapeutics, Inc. /de/1,158 sharesdown −97.8%down −97.7%
19 Dec 201923 Dec 2019SEC Form 44 dwas grantednot a tradeHeron Therapeutics, Inc. /de/derivative120,000 sharesdown −98.7%down −98.7%
29 Nov 20193 Dec 2019SEC Form 44 dexercised options overnot a tradeHeron Therapeutics, Inc. /de/derivative24,000 sharesdown −98.8%down −98.8%
29 Nov 20193 Dec 2019SEC Form 44 dexercised options overnot a tradeHeron Therapeutics, Inc. /de/24,000 sharesdown −98.8%down −98.8%
29 Nov 20193 Dec 2019SEC Form 44 dsold on the open marketHeron Therapeutics, Inc. /de/24,000 sharesdown −98.8%down −98.8%
1 May 20192 May 2019SEC Form 41 dsold on the open marketHeron Therapeutics, Inc. /de/1,109 sharesdown −98.2%down −98.2%
30 Apr 20192 May 2019SEC Form 42 dacquired or disposed of, othernot a tradeHeron Therapeutics, Inc. /de/1,109 sharesdown −98.5%down −98.2%
15 Dec 201818 Dec 2018SEC Form 43 dwas grantednot a tradeHeron Therapeutics, Inc. /de/derivative100,000 sharesdown −98.7%down −98.7%
2 Nov 20182 Nov 2018SEC Form 40 dsold on the open marketHeron Therapeutics, Inc. /de/494 sharesdown −99.0%down −99.0%
31 Oct 20182 Nov 2018SEC Form 42 dacquired or disposed of, othernot a tradeHeron Therapeutics, Inc. /de/494 sharesdown −98.9%down −99.0%
1 Oct 20182 Oct 2018SEC Form 41 dexercised options overnot a tradeHeron Therapeutics, Inc. /de/derivative6,000 sharesdown −99.0%down −99.0%
1 Oct 20182 Oct 2018SEC Form 41 dexercised options overnot a tradeHeron Therapeutics, Inc. /de/6,000 sharesdown −99.0%down −99.0%
1 Oct 20182 Oct 2018SEC Form 41 dsold on the open marketHeron Therapeutics, Inc. /de/6,000 sharesdown −99.0%down −99.0%
2 Jul 20183 Jul 2018SEC Form 41 dexercised options overnot a tradeHeron Therapeutics, Inc. /de/derivative6,000 sharesdown −99.2%down −99.2%
2 Jul 20183 Jul 2018SEC Form 41 dexercised options overnot a tradeHeron Therapeutics, Inc. /de/6,000 sharesdown −99.2%down −99.2%
2 Jul 20183 Jul 2018SEC Form 41 dsold on the open marketHeron Therapeutics, Inc. /de/5,900 sharesdown −99.2%down −99.2%
2 Jul 20183 Jul 2018SEC Form 41 dsold on the open marketHeron Therapeutics, Inc. /de/100 sharesdown −99.2%down −99.2%
19 Mar 201819 Mar 2018SEC Form 40 dexercised options overnot a tradeHeron Therapeutics, Inc. /de/18,000 sharesdown −98.8%down −98.8%
19 Mar 201819 Mar 2018SEC Form 40 dsold on the open marketHeron Therapeutics, Inc. /de/18,000 sharesdown −98.8%down −98.8%
19 Mar 201819 Mar 2018SEC Form 40 dexercised options overnot a tradeHeron Therapeutics, Inc. /de/derivative18,000 sharesdown −98.8%down −98.8%
10 Jan 201812 Jan 2018SEC Form 42 dexercised options overnot a tradeHeron Therapeutics, Inc. /de/derivative7,584 sharesdown −98.4%down −98.5%
10 Jan 201812 Jan 2018SEC Form 42 dexercised options overnot a tradeHeron Therapeutics, Inc. /de/7,584 sharesdown −98.4%down −98.5%
10 Jan 201812 Jan 2018SEC Form 42 dsold on the open marketHeron Therapeutics, Inc. /de/7,584 sharesdown −98.4%down −98.5%
18 Dec 201720 Dec 2017SEC Form 42 dwas grantednot a tradeHeron Therapeutics, Inc. /de/derivative120,000 sharesdown −98.1%down −98.2%
24 Apr 201724 Apr 2017SEC Form 40 dexercised options overnot a tradeHeron Therapeutics, Inc. /de/5,250 sharesdown −97.9%down −97.9%
24 Apr 201724 Apr 2017SEC Form 40 dexercised options overnot a tradeHeron Therapeutics, Inc. /de/16,292 sharesdown −97.9%down −97.9%
24 Apr 201724 Apr 2017SEC Form 40 dsold on the open marketHeron Therapeutics, Inc. /de/21,542 sharesdown −97.9%down −97.9%
24 Apr 201724 Apr 2017SEC Form 40 dexercised options overnot a tradeHeron Therapeutics, Inc. /de/derivative5,250 sharesdown −97.9%down −97.9%
24 Apr 201724 Apr 2017SEC Form 40 dexercised options overnot a tradeHeron Therapeutics, Inc. /de/derivative16,292 sharesdown −97.9%down −97.9%
21 Dec 201623 Dec 2016SEC Form 42 dwas grantednot a tradeHeron Therapeutics, Inc. /de/derivative120,000 sharesdown −97.6%down −97.6%
28 Jan 201629 Jan 2016SEC Form 41 dwas grantednot a tradeHeron Therapeutics, Inc. /de/derivative300,000 sharesdown −98.5%down −98.5%
22 Dec 201524 Dec 2015SEC Form 42 dwas grantednot a tradeHeron Therapeutics, Inc. /de/derivative19,000 sharesdown −98.9%down −98.9%
2 Jun 20153 Jun 2015SEC Form 41 dexercised options overnot a tradeHeron Therapeutics, Inc. /de/10,500 sharesdown −98.6%down −98.8%
2 Jun 20153 Jun 2015SEC Form 41 dsold on the open marketHeron Therapeutics, Inc. /de/10,500 sharesdown −98.6%down −98.8%
2 Jun 20153 Jun 2015SEC Form 41 dexercised options overnot a tradeHeron Therapeutics, Inc. /de/derivative10,500 sharesdown −98.6%down −98.8%
1 Jun 20153 Jun 2015SEC Form 42 dexercised options overnot a tradeHeron Therapeutics, Inc. /de/2,708 sharesdown −98.7%down −98.8%
1 Jun 20153 Jun 2015SEC Form 42 dsold on the open marketHeron Therapeutics, Inc. /de/2,708 sharesdown −98.7%down −98.8%
1 Jun 20153 Jun 2015SEC Form 42 dexercised options overnot a tradeHeron Therapeutics, Inc. /de/derivative2,708 sharesdown −98.7%down −98.8%
12 Dec 201415 Dec 2014SEC Form 43 dwas grantednot a tradeHeron Therapeutics, Inc. /de/derivative19,000 sharesdown −96.5%down −96.5%
19 Jun 201220 Jun 2012SEC Form 41 dexercised options overnot a tradeArdea Biosciences, Inc./DEderivative4,375 shares——
19 Jun 201220 Jun 2012SEC Form 41 dexercised options overnot a tradeArdea Biosciences, Inc./DEderivative2,906 shares——
19 Jun 201220 Jun 2012SEC Form 41 dexercised options overnot a tradeArdea Biosciences, Inc./DEderivative5,548 shares——
19 Jun 201220 Jun 2012SEC Form 41 dexercised options overnot a tradeArdea Biosciences, Inc./DE4,375 shares——
19 Jun 201220 Jun 2012SEC Form 41 dexercised options overnot a tradeArdea Biosciences, Inc./DE2,906 shares——
19 Jun 201220 Jun 2012SEC Form 41 dexercised options overnot a tradeArdea Biosciences, Inc./DE5,548 shares——
19 Jun 201220 Jun 2012SEC Form 41 dsold on the open marketArdea Biosciences, Inc./DE12,829 shares——
19 Jun 201220 Jun 2012SEC Form 41 dreturned to the issuernot a tradeArdea Biosciences, Inc./DEderivative5,000 shares——
19 Jun 201220 Jun 2012SEC Form 41 dreturned to the issuernot a tradeArdea Biosciences, Inc./DEderivative25,625 shares——
19 Jun 201220 Jun 2012SEC Form 41 dreturned to the issuernot a tradeArdea Biosciences, Inc./DEderivative34,452 shares——
19 Jun 201220 Jun 2012SEC Form 41 dreturned to the issuernot a tradeArdea Biosciences, Inc./DEderivative49,000 shares——
19 Jun 201220 Jun 2012SEC Form 41 dreturned to the issuernot a tradeArdea Biosciences, Inc./DEderivative9,595 shares——
19 Jun 201220 Jun 2012SEC Form 41 dreturned to the issuernot a tradeArdea Biosciences, Inc./DEderivative27,499 shares——
19 Jun 201220 Jun 2012SEC Form 41 dreturned to the issuernot a tradeArdea Biosciences, Inc./DEderivative4,226 shares——
19 Jun 201220 Jun 2012SEC Form 41 dreturned to the issuernot a tradeArdea Biosciences, Inc./DEderivative35,774 shares——
19 Jun 201220 Jun 2012SEC Form 41 dreturned to the issuernot a tradeArdea Biosciences, Inc./DEderivative5,279 shares——
19 Jun 201220 Jun 2012SEC Form 41 dreturned to the issuernot a tradeArdea Biosciences, Inc./DEderivative34,721 shares——
19 Jun 201220 Jun 2012SEC Form 41 dreturned to the issuernot a tradeArdea Biosciences, Inc./DE10,200 shares——
29 May 201229 May 2012SEC Form 40 dexercised options overnot a tradeArdea Biosciences, Inc./DEderivative5,000 shares——
29 May 201229 May 2012SEC Form 40 dexercised options overnot a tradeArdea Biosciences, Inc./DE5,000 shares——
29 May 201229 May 2012SEC Form 40 dsold on the open marketArdea Biosciences, Inc./DE5,000 shares——
30 Apr 201230 Apr 2012SEC Form 40 dexercised options overnot a tradeArdea Biosciences, Inc./DEderivative5,000 shares——
30 Apr 201230 Apr 2012SEC Form 40 dexercised options overnot a tradeArdea Biosciences, Inc./DE5,000 shares——
30 Apr 201230 Apr 2012SEC Form 40 dsold on the open marketArdea Biosciences, Inc./DE5,000 shares——
28 Mar 201229 Mar 2012SEC Form 41 dexercised options overnot a tradeArdea Biosciences, Inc./DEderivative5,000 shares——
28 Mar 201229 Mar 2012SEC Form 41 dexercised options overnot a tradeArdea Biosciences, Inc./DE5,000 shares——
28 Mar 201229 Mar 2012SEC Form 41 dsold on the open marketArdea Biosciences, Inc./DE5,000 shares——
28 Feb 201229 Feb 2012SEC Form 41 dexercised options overnot a tradeArdea Biosciences, Inc./DEderivative5,000 shares——
28 Feb 201229 Feb 2012SEC Form 41 dexercised options overnot a tradeArdea Biosciences, Inc./DE5,000 shares——
28 Feb 201229 Feb 2012SEC Form 41 dsold on the open marketArdea Biosciences, Inc./DE5,000 shares——
30 Jan 201231 Jan 2012SEC Form 41 dexercised options overnot a tradeArdea Biosciences, Inc./DEderivative5,000 shares——
30 Jan 201231 Jan 2012SEC Form 41 dexercised options overnot a tradeArdea Biosciences, Inc./DE5,000 shares——
30 Jan 201231 Jan 2012SEC Form 41 dsold on the open marketArdea Biosciences, Inc./DE5,000 shares——
28 Dec 201129 Dec 2011SEC Form 41 dexercised options overnot a tradeArdea Biosciences, Inc./DEderivative5,000 shares——
28 Dec 201129 Dec 2011SEC Form 41 dexercised options overnot a tradeArdea Biosciences, Inc./DE5,000 shares——
28 Dec 201129 Dec 2011SEC Form 41 dsold on the open marketArdea Biosciences, Inc./DE5,000 shares——
16 Dec 201120 Dec 2011SEC Form 44 dwas grantednot a tradeArdea Biosciences, Inc./DEderivative40,000 shares——
28 Nov 201129 Nov 2011SEC Form 41 dexercised options overnot a tradeArdea Biosciences, Inc./DEderivative5,000 shares——
28 Nov 201129 Nov 2011SEC Form 41 dexercised options overnot a tradeArdea Biosciences, Inc./DE5,000 shares——
28 Nov 201129 Nov 2011SEC Form 41 dsold on the open marketArdea Biosciences, Inc./DE5,000 shares——
28 Oct 201128 Oct 2011SEC Form 40 dexercised options overnot a tradeArdea Biosciences, Inc./DEderivative5,000 shares——
28 Oct 201128 Oct 2011SEC Form 40 dexercised options overnot a tradeArdea Biosciences, Inc./DE5,000 shares——
28 Oct 201128 Oct 2011SEC Form 40 dsold on the open marketArdea Biosciences, Inc./DE5,000 shares——
28 Sep 201130 Sep 2011SEC Form 42 dexercised options overnot a tradeArdea Biosciences, Inc./DEderivative5,000 shares——
28 Sep 201130 Sep 2011SEC Form 42 dexercised options overnot a tradeArdea Biosciences, Inc./DE5,000 shares——
28 Sep 201130 Sep 2011SEC Form 42 dsold on the open marketArdea Biosciences, Inc./DE5,000 shares——
29 Aug 201130 Aug 2011SEC Form 41 dexercised options overnot a tradeArdea Biosciences, Inc./DEderivative5,000 shares——
29 Aug 201130 Aug 2011SEC Form 41 dexercised options overnot a tradeArdea Biosciences, Inc./DE5,000 shares——
29 Aug 201130 Aug 2011SEC Form 41 dsold on the open marketArdea Biosciences, Inc./DE5,000 shares——
28 Jul 201129 Jul 2011SEC Form 41 dexercised options overnot a tradeArdea Biosciences, Inc./DEderivative5,000 shares——
28 Jul 201129 Jul 2011SEC Form 41 dexercised options overnot a tradeArdea Biosciences, Inc./DE5,000 shares——
28 Jul 201129 Jul 2011SEC Form 41 dsold on the open marketArdea Biosciences, Inc./DE5,000 shares——
28 Jun 201129 Jun 2011SEC Form 41 dexercised options overnot a tradeArdea Biosciences, Inc./DEderivative5,000 shares——
28 Jun 201129 Jun 2011SEC Form 41 dexercised options overnot a tradeArdea Biosciences, Inc./DE5,000 shares——
28 Jun 201129 Jun 2011SEC Form 41 dsold on the open marketArdea Biosciences, Inc./DE5,000 shares——
31 May 20111 Jun 2011SEC Form 41 dexercised options overnot a tradeArdea Biosciences, Inc./DEderivative5,000 shares——
31 May 20111 Jun 2011SEC Form 41 dexercised options overnot a tradeArdea Biosciences, Inc./DE5,000 shares——
31 May 20111 Jun 2011SEC Form 41 dsold on the open marketArdea Biosciences, Inc./DE5,000 shares——
28 Apr 201129 Apr 2011SEC Form 41 dexercised options overnot a tradeArdea Biosciences, Inc./DEderivative5,000 shares——
28 Apr 201129 Apr 2011SEC Form 41 dexercised options overnot a tradeArdea Biosciences, Inc./DE5,000 shares——
28 Apr 201129 Apr 2011SEC Form 41 dsold on the open marketArdea Biosciences, Inc./DE5,000 shares——
28 Mar 201129 Mar 2011SEC Form 41 dexercised options overnot a tradeArdea Biosciences, Inc./DEderivative5,000 shares——
28 Mar 201129 Mar 2011SEC Form 41 dexercised options overnot a tradeArdea Biosciences, Inc./DE5,000 shares——
28 Mar 201129 Mar 2011SEC Form 41 dsold on the open marketArdea Biosciences, Inc./DE5,000 shares——
28 Feb 20111 Mar 2011SEC Form 41 dexercised options overnot a tradeArdea Biosciences, Inc./DEderivative5,000 shares——
28 Feb 20111 Mar 2011SEC Form 41 dexercised options overnot a tradeArdea Biosciences, Inc./DE5,000 shares——
28 Feb 20111 Mar 2011SEC Form 41 dsold on the open marketArdea Biosciences, Inc./DE5,000 shares——
28 Jan 201128 Jan 2011SEC Form 40 dexercised options overnot a tradeArdea Biosciences, Inc./DEderivative5,000 shares——
28 Jan 201128 Jan 2011SEC Form 40 dexercised options overnot a tradeArdea Biosciences, Inc./DE5,000 shares——
28 Jan 201128 Jan 2011SEC Form 40 dsold on the open marketArdea Biosciences, Inc./DE5,000 shares——
30 Dec 201030 Dec 2010SEC Form 40 dexercised options overnot a tradeArdea Biosciences, Inc./DEderivative5,000 shares——
30 Dec 201030 Dec 2010SEC Form 40 dexercised options overnot a tradeArdea Biosciences, Inc./DE5,000 shares——
28 Dec 201030 Dec 2010SEC Form 42 dexercised options overnot a tradeArdea Biosciences, Inc./DEderivative5,000 shares——
28 Dec 201030 Dec 2010SEC Form 42 dexercised options overnot a tradeArdea Biosciences, Inc./DE5,000 shares——
28 Dec 201030 Dec 2010SEC Form 42 dsold on the open marketArdea Biosciences, Inc./DE5,000 shares——
14 Dec 201016 Dec 2010SEC Form 42 dwas grantednot a tradeArdea Biosciences, Inc./DEderivative40,000 shares——
29 Nov 201030 Nov 2010SEC Form 41 dexercised options overnot a tradeArdea Biosciences, Inc./DEderivative5,000 shares——
29 Nov 201030 Nov 2010SEC Form 41 dexercised options overnot a tradeArdea Biosciences, Inc./DE5,000 shares——
29 Nov 201030 Nov 2010SEC Form 41 dsold on the open marketArdea Biosciences, Inc./DE5,000 shares——
28 Oct 20101 Nov 2010SEC Form 44 dexercised options overnot a tradeArdea Biosciences, Inc./DEderivative5,000 shares——
28 Oct 20101 Nov 2010SEC Form 44 dexercised options overnot a tradeArdea Biosciences, Inc./DE5,000 shares——
28 Oct 20101 Nov 2010SEC Form 44 dsold on the open marketArdea Biosciences, Inc./DE5,000 shares——
28 Sep 201030 Sep 2010SEC Form 42 dexercised options overnot a tradeArdea Biosciences, Inc./DEderivative5,000 shares——
28 Sep 201030 Sep 2010SEC Form 42 dexercised options overnot a tradeArdea Biosciences, Inc./DE5,000 shares——
28 Sep 201030 Sep 2010SEC Form 42 dsold on the open marketArdea Biosciences, Inc./DE5,000 shares——
30 Aug 20101 Sep 2010SEC Form 42 dexercised options overnot a tradeArdea Biosciences, Inc./DEderivative5,000 shares——
30 Aug 20101 Sep 2010SEC Form 42 dexercised options overnot a tradeArdea Biosciences, Inc./DE5,000 shares——
30 Aug 20101 Sep 2010SEC Form 42 dsold on the open marketArdea Biosciences, Inc./DE8,968 shares——
28 Jul 201029 Jul 2010SEC Form 41 dexercised options overnot a tradeArdea Biosciences, Inc./DEderivative2,500 shares——
28 Jul 201029 Jul 2010SEC Form 41 dexercised options overnot a tradeArdea Biosciences, Inc./DE2,500 shares——
28 Jul 201029 Jul 2010SEC Form 41 dsold on the open marketArdea Biosciences, Inc./DE2,500 shares——
28 Jun 201029 Jun 2010SEC Form 41 dexercised options overnot a tradeArdea Biosciences, Inc./DEderivative2,500 shares——
28 Jun 201029 Jun 2010SEC Form 41 dexercised options overnot a tradeArdea Biosciences, Inc./DE2,500 shares——
28 Jun 201029 Jun 2010SEC Form 41 dsold on the open marketArdea Biosciences, Inc./DE2,500 shares——
28 May 20101 Jun 2010SEC Form 44 dexercised options overnot a tradeArdea Biosciences, Inc./DEderivative2,500 shares——
28 May 20101 Jun 2010SEC Form 44 dexercised options overnot a tradeArdea Biosciences, Inc./DE2,500 shares——
28 May 20101 Jun 2010SEC Form 44 dsold on the open marketArdea Biosciences, Inc./DE2,300 shares——
28 May 20101 Jun 2010SEC Form 44 dsold on the open marketArdea Biosciences, Inc./DE200 shares——
28 Apr 201029 Apr 2010SEC Form 41 dexercised options overnot a tradeArdea Biosciences, Inc./DEderivative2,500 shares——
28 Apr 201029 Apr 2010SEC Form 41 dexercised options overnot a tradeArdea Biosciences, Inc./DE2,500 shares——
28 Apr 201029 Apr 2010SEC Form 41 dsold on the open marketArdea Biosciences, Inc./DE2,500 shares——
29 Mar 201030 Mar 2010SEC Form 41 dexercised options overnot a tradeArdea Biosciences, Inc./DEderivative2,500 shares——
29 Mar 201030 Mar 2010SEC Form 41 dexercised options overnot a tradeArdea Biosciences, Inc./DE2,500 shares——
29 Mar 201030 Mar 2010SEC Form 41 dsold on the open marketArdea Biosciences, Inc./DE2,500 shares——
26 Feb 20101 Mar 2010SEC Form 43 dexercised options overnot a tradeArdea Biosciences, Inc./DEderivative2,500 shares——
26 Feb 20101 Mar 2010SEC Form 43 dexercised options overnot a tradeArdea Biosciences, Inc./DE2,500 shares——
26 Feb 20101 Mar 2010SEC Form 43 dsold on the open marketArdea Biosciences, Inc./DE2,500 shares——
28 Jan 201029 Jan 2010SEC Form 41 dexercised options overnot a tradeArdea Biosciences, Inc./DEderivative2,500 shares——
28 Jan 201029 Jan 2010SEC Form 41 dexercised options overnot a tradeArdea Biosciences, Inc./DE2,500 shares——
28 Jan 201029 Jan 2010SEC Form 41 dsold on the open marketArdea Biosciences, Inc./DE2,500 shares——
28 Dec 200929 Dec 2009SEC Form 41 dexercised options overnot a tradeArdea Biosciences, Inc./DEderivative2,500 shares——
28 Dec 200929 Dec 2009SEC Form 41 dexercised options overnot a tradeArdea Biosciences, Inc./DE2,500 shares——
28 Dec 200929 Dec 2009SEC Form 41 dsold on the open marketArdea Biosciences, Inc./DE2,500 shares——
16 Dec 200918 Dec 2009SEC Form 42 dwas grantednot a tradeArdea Biosciences, Inc./DEderivative40,000 shares——
27 Nov 20091 Dec 2009SEC Form 44 dexercised options overnot a tradeArdea Biosciences, Inc./DEderivative2,500 shares——
27 Nov 20091 Dec 2009SEC Form 44 dexercised options overnot a tradeArdea Biosciences, Inc./DE2,500 shares——
27 Nov 20091 Dec 2009SEC Form 44 dsold on the open marketArdea Biosciences, Inc./DE2,500 shares——
28 Oct 200929 Oct 2009SEC Form 41 dexercised options overnot a tradeArdea Biosciences, Inc./DEderivative2,500 shares——
28 Oct 200929 Oct 2009SEC Form 41 dexercised options overnot a tradeArdea Biosciences, Inc./DE2,500 shares——
28 Oct 200929 Oct 2009SEC Form 41 dsold on the open marketArdea Biosciences, Inc./DE2,500 shares——
28 Sep 200929 Sep 2009SEC Form 41 dexercised options overnot a tradeArdea Biosciences, Inc./DEderivative2,500 shares——
28 Sep 200929 Sep 2009SEC Form 41 dexercised options overnot a tradeArdea Biosciences, Inc./DE2,500 shares——
28 Sep 200929 Sep 2009SEC Form 41 dsold on the open marketArdea Biosciences, Inc./DE2,500 shares——
28 Aug 200931 Aug 2009SEC Form 43 dexercised options overnot a tradeArdea Biosciences, Inc./DEderivative2,500 shares——
28 Aug 200931 Aug 2009SEC Form 43 dexercised options overnot a tradeArdea Biosciences, Inc./DE2,500 shares——
28 Aug 200931 Aug 2009SEC Form 43 dsold on the open marketArdea Biosciences, Inc./DE2,500 shares——
19 May 200921 May 2009SEC Form 42 dexercised options overnot a tradeArdea Biosciences, Inc./DEderivative25,000 shares——
19 May 200921 May 2009SEC Form 42 dexercised options overnot a tradeArdea Biosciences, Inc./DE25,000 shares——
19 May 200921 May 2009SEC Form 42 dsold on the open marketArdea Biosciences, Inc./DE21,300 shares——
19 Dec 200816 Jan 2009SEC Form 428 dwas grantednot a tradeArdea Biosciences, Inc./DEderivative49,000 shares——
19 Dec 200819 Dec 2008SEC Form 40 dwas grantednot a tradeArdea Biosciences, Inc./DEderivative44,000 shares——
2 Jan 20084 Jan 2008SEC Form 42 dwas grantednot a tradeArdea Biosciences, Inc./DEderivative40,000 shares——
26 Jul 200730 Jul 2007SEC Form 44 dwas grantednot a tradeArdea Biosciences, Inc./DEderivative30,000 shares——
21 Dec 200622 Dec 2006SEC Form 41 dwas grantednot a tradeIntrabiotics Pharmaceuticals Inc /dederivative175,000 shares——

Both percentages are the stock’s move, not Kimberly Manhard’s return: a disclosure gives a band, never an amount, so nobody can say how much was bought or what it made. They run to the last close we hold — 11 Sep 2026, except where a name has since delisted, when the row names its own last session. We publish no close, no volume and no dollar figure behind them. 107 of the 245 rows shown carry a percentage; the rest are dashes with the reason on the row.

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.

Some filings reach us as photographs of paper rather than as a form we can read as text. Those are shown here only once they have been read and checked, so this page can hold fewer lines than the filings behind it contain. The link on every row opens the original document, which is always the full record.